At its annual conference and expo (Palm Desert, CA, March 10-13), the Healthcare Distribution Alliance awarded its Distribution management Award to two innovative projects in pharma distribution: the MediLedger Project, managed by Chronicled, and the Cubixx CT At-Home Clinical Trial Inventory Management Solution. MediLedger was the winner; Cubixx was the merit finalist.
The MediLedger Project, hosted by Chronicled, is a verification system that provides a synchronized and secure method to manage an “industry phonebook” of Global Trade Item Numbers (GTINs), enabling trading partners to know where to execute a systemic verification request. The system employs blockchain technology to eliminate the need for individual wholesalers to manage large volumes of product lists and manufacturer addresses, complying with DSCSA regulations while reducing errors and providing savings to the entire supply chain. Participants who were involved in the MediLedger demonstration are AbbVie US; AmerisourceBergen; Roche/Genentech; McKesson and Pfizer.
“The 2019 DMA winners saw a problem, came together, strategized and worked together to find a solution for the benefit of all. The Alliance is proud to honor these organizations, who sought to benefit the patients they ultimately serve through industry collaboration and innovation,” said Perry Fri, HDA EVP of Industry Relations, Membership and Education; and COO, HDA Research Foundation.
AmerisourceBergen’s Cubixx solution has been undergoing continual evolution for years; the latest iteration is tailored for managing clinical trial supplies at the home of the trial participant. Besides storing trial materials under monitored conditions, the refrigerator is RFID- and standalone-cellular-enabled, thus allowing trial coordinators to monitor dosage applications and inventory, and providing alerts.